Suppr超能文献

多能干细胞来源的人类多细胞肝类器官的生成。

Generation of multi-cellular human liver organoids from pluripotent stem cells.

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

出版信息

Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.

Abstract

A growing number of in vitro hepatic models exist to study human genetics, liver biology, disease modeling and drug development and range from 2D hepatocytes to 3D multi-cellular tissues that are derived from human stem cells. However, stem cell-based models generally suffer from batch-, clone- and donor-dependent variability, hindering broader usage in diverse biomedical applications. To circumvent this challenge, we herein describe a reproducible protocol to generate human liver organoids in 20-25 days derived from pluripotent stem cells (PSCs). These organoids are intra-luminally polarized to form canalicular structures and are comprised of mainly hepatic epithelial cells, co-differentiated with stellate-like and hepatic macrophage-like cells that enables hepatic inflammatory disease modeling in vitro. These multi-lineage liver organoids express hepatocyte genes, secrete albumin and have vital metabolic functions. This protocol utilizes PSC derived 3D human liver organoids as a renewable, reproducible and personalized cell source, thus facilitating disease modeling and mechanistic studies with a future goal of developing novel therapeutics against currently intractable diseases.

摘要

越来越多的体外肝脏模型被用于研究人类遗传学、肝脏生物学、疾病建模和药物开发,范围从 2D 肝细胞到源自人类干细胞的 3D 多细胞组织。然而,基于干细胞的模型通常存在批次、克隆和供体依赖性变异性,这阻碍了它们在各种生物医学应用中的广泛使用。为了克服这一挑战,我们在此描述了一种在 20-25 天内从多能干细胞 (PSC) 生成人类肝类器官的可重复协议。这些类器官在腔内向极化形成胆小管结构,并主要由肝细胞组成,与星状细胞和肝巨噬细胞样细胞共分化,从而能够在体外进行肝炎症性疾病建模。这些多能性肝类器官表达肝细胞基因,分泌白蛋白,并具有重要的代谢功能。该方案利用 PSC 衍生的 3D 人类肝类器官作为可再生、可重复和个性化的细胞来源,从而促进疾病建模和机制研究,未来的目标是开发针对目前难以治疗疾病的新型治疗方法。

相似文献

9
Stem cell-derived kidney organoids: engineering the vasculature.干细胞衍生的肾脏类器官:血管工程。
Cell Mol Life Sci. 2020 Jun;77(12):2257-2273. doi: 10.1007/s00018-019-03401-0. Epub 2019 Dec 5.

引用本文的文献

2
Organoid-Guided Precision Medicine: From Bench to Bedside.类器官引导的精准医学:从实验室到临床
MedComm (2020). 2025 May 1;6(5):e70195. doi: 10.1002/mco2.70195. eCollection 2025 May.
4
Hepatobiliary organoid research: the progress and applications.肝胆类器官研究:进展与应用
Front Pharmacol. 2025 Feb 11;16:1473863. doi: 10.3389/fphar.2025.1473863. eCollection 2025.

本文引用的文献

6
Organoids of liver diseases: From bench to bedside.肝脏疾病类器官:从基础研究到临床应用。
World J Gastroenterol. 2019 Apr 28;25(16):1913-1927. doi: 10.3748/wjg.v25.i16.1913.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验